MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology _Monoclonal, Polyclonal, Bispecific Antibodies & Antibody-Drug Conjugates (ADC)s
Immunome, Inc. (NASDAQ: IMNM)*
Organization & Developments: Immunome
Parents
Immunome, Inc. (NASDAQ: IMNM)*
Children
2012: Pennsylvania human antibody cloning company raising $1.5 million (2012)
2023: Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
2023: Betting on cell memory, AbbVie pays Immunome $30M upfront to further antibody research
2023: Immunome: The Morphimmune Merger And The Pipeline
2024: Immunome Advances with Strategic Asset Acquisition and Agreement
2024: Immunome: A Recently Acquired Lead Asset And A Small Market_seekingalpha.com
2024: Immunome: An Oncology Powerhouse In The Making
2024: Immunome: Why It Has Doubled Over The Last Month_ seekingalpha.com
2025: Immunome Can Take The Fight To Competitors With Varegacestat
2025: Immunome's Massive $125M Capital Raise Could Reshape Cancer Treatment Landscape
2026: Immunome: Maintaining My 'Strong Buy' Rating With 2 Catalysts On The Horizon
Jumps
Finance & Acquisitions: Immunome
Key People: Immunome